You Should Stop Hating on J&J’s Device Business

johnson-johnson-logoJohnson & Johnson has been working behind the scenes to turn around its massive $25 billion-a-year medical device business.

The efforts appear to be paying off.

After it held its annual analyst day Wednesday, many analysts now believe that the company’s device business will grow greater than the overall medtech market growth of 4–6%.

Before delving into how it will achieve the above-market growth, it’s worthwhile to understand the device business segments and how they performed last year.

The Hospital Medical Devices business has a pipeline of products that are set to be filed by 2018. The pipeline cumulatively has the potential to generate more than $6 billion in sales, according to a presentation by Gary Pruden, who leads the hospital medical device business at Johnson & Johnson.

READ MORE

 

About Peter Coffaro 1060 Articles
A growth-driven and strategic executive, Peter Coffaro commands more than 20 years of progressive management success within the medical device industry. As a District Sales Manager for Stryker Orthopaedics, Peter was responsible for managing and directing a regional sales force to achieve sales and profit goals within the Rocky Mountain region. Previously, he was the Director of Sales & Marketing for Amp Orthopedics. In this role, Peter was responsible for planning, developing, and leading all sales and marketing initiatives. Peter is a former orthopedic distributor in the Pacific Northwest. He has also worked with DePuy Orthopaedics as well as Zimmer, and held positions in sales, sales training, and sales management. Peter has an extensive background in organizational development, business development, sales management, negotiating and P&L management. Peter holds a B.S. degree in Biology from Northern Illinois University.

Be the first to comment

Leave a Reply

Your email address will not be published.


*